Clinical efficacy and Influence of Kanglaite Combined with Chemotherapy on the Activity of Immune Cells in Patients with Liver Cancer

Objective: To observe the clinical effects of Kanglaite applied to the chemotherapy on the activity of immune cells in patients with liver cancer. Methods: 150 patients who were diagnosed the liver cancer were collected and randomly divided into the control group and the treatment group by average. The patients in the control group were treated by chemotherapy with western medicine, while the patients in the treatment group were treated by Kanglaite combined with the chemotherapy mixed with the western medicine. After treating for two months, the recent curative effect, variation of body weight, the improvement of the life quality, the adverse reaction of patients were observed. The survival rate of one-year, three-year and five-year after the treatment was analyzed and the activity of immune cells in patients was compared before and after the treatment. Results: The rate of short-term efficacy of patients in the control group was 44% and 68% in the treatment group with statistically significant differences(P0.05); The improvement of life quality of patients in the control groups was 33.3%, while in the treatment group was 66.7% with statistically significant difference(P0.05); The variation of body weight in the control group was 21.3%, while in the treatment group was 24% with statistically significant difference(P0.05); The rate of survival in the treatment group was higher than that of the control group when treated for one-year, three-year and five-year later; The activity of immunity of patients in the treatment group were significantly improved after treatment, and the immuno-logical indexes of patients in the two groups after treatment were significantly different; The adverse reaction of patients in the control group is significantly higher than that of the treatment group(P0.05). Conclusions: It is indicated that the application of Kanglaite combined with chemotherapy should be well promoted in the clinical field with the advantages of better efficacy, and the stimulation of immune cells' activity for the patients with liver cancer.